Companies / Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc.
Financials · FY2025
Ownership
61.6M shares outstanding · as of Jul 30, 2026
Ownership
| Insiders | 1.41% | 867,712 |
| 10%+ / strategic | 6.49% | 4,000,000 |
| Institutions | 52.16% | 32,142,584 |
| Public float | 39.94% | 24,607,652 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Sandrock AlfredCEOPresident and CEO · Director | 0.79% | 484,060 |
Swartz RobinCOO & CBO | 0.32% | 199,738 |
Ferguson TobyChief Medical Officer | 0.30% | 183,914 |
Jorgensen Nathan D.FormerChief Financial Officer | 0.25% | 151,416 |
Carter Todd AlfredFormerChief Scientific Officer | 0.24% | 145,718 |
Geraghty James aDirector | — | — |
Pierce GlennDirector | — | — |
Scangos George aDirector | — | — |
Shiferman Gregory L.FormerSVP and General Counsel | — | — |
Institutional holders 130
View all →| Holder | Value | % of shares |
|---|---|---|
| $18.10M | 8.39% | |
| $15.73M | 6.50% | |
| $15.72M | 6.49% | |
| $13.23M | 5.56% | |
| $12.84M | 5.30% | |
| $5.80M | 2.39% | |
| $4.72M | 1.94% | |
| $4.70M | 1.94% | |
| $4.26M | 1.76% | |
| $4.05M | 1.70% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | Common stock | $5.97M | +1.5M +82.30% | 3,428,571 5.56% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Trim | Common stock | $-1.56M | -446K -7.94% | 5,172,063 8.39% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | Common stock | $1.52M | +393K +176.44% | 615,660 1.00% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Add | Common stock | $1.09M | +282K +94.98% | 578,024 0.94% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Trim | Common stock | $-987.7K | -251K -58.80% | 176,097 0.29% of shares | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common stock | $603.1K | +156K | 156,250 0.25% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common stock | $490.5K | +140K +14.97% | 1,076,422 1.75% of shares | low |
| Q4 2023 as of | Barclays PLC 13F manager | Add | Common stock | $404.2K | +48K +261.58% | 66,201 0.11% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Integrated Core Strategies (US) LLC | Passive13G | — |
| EcoR1 Capital, LLC | Passive13G/A | — |
| Armistice Capital, LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| VYGR | — | 92915B106 |